Compass Therapeutics Inc. (CMPX)
NASDAQ: CMPX
· Real-Time Price · USD
2.98
0.03 (1.02%)
At close: Aug 15, 2025, 3:59 PM
2.97
-0.34%
After-hours: Aug 15, 2025, 05:01 PM EDT
Compass Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | 850K | 850K | 3.69M | 3.69M | 2.84M | 2.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 367K | n/a | 463K | 931K | 1.4M | 1.87M | 1.89M | 1.91M | 1.93M | 1.95M | 1.9M | 1.82M | 1.74M | 1.65M | 1.62M | 1.23M | 822K | 413K |
Gross Profit | -367K | 850K | 387K | 2.76M | 2.3M | 972K | 954K | -1.91M | -1.93M | -1.95M | -1.9M | -1.82M | -1.74M | -1.65M | -1.62M | -1.23M | -822K | -413K |
Operating Income | -67.84M | -61.82M | -56.63M | -55.45M | -55.13M | -53.43M | -50.37M | -47.86M | -48.53M | -44.18M | -41.66M | -41.77M | -35.02M | -81.73M | -81.88M | -76.83M | -79.94M | -29.32M |
Interest Income | 4.53M | 5.32M | 5.32M | 5.71M | 5.91M | 6M | 6M | 5.32M | 3.98M | 2.34M | 2.36M | 1.07M | 449K | 34K | 29K | 43K | 64K | 62K |
Pretax Income | -62.03M | -55.22M | -49.38M | -47.76M | -47.24M | -45.44M | -42.49M | -40.67M | -42.68M | -39.9M | -39.23M | -40.63M | -34.63M | -81.92M | -82.18M | -77.58M | -80.75M | -30.5M |
Net Income | -62.03M | -55.22M | -49.38M | -47.76M | -47.24M | -45.44M | -40.62M | -37.51M | -38.89M | -35.62M | -36.8M | -39.48M | -34.1M | -81.9M | -82.18M | -77.59M | -80.77M | -30.52M |
Selling & General & Admin | 16.73M | 16.8M | 14.82M | 13.95M | 13.41M | 11.81M | 11.94M | 12.24M | 11.95M | 11.96M | 11.66M | 12.13M | 12.02M | 11.06M | 10.93M | 11.04M | 13.64M | 13.55M |
Research & Development | 51.12M | 45.88M | 42.19M | 41.42M | 41.64M | 40.69M | 37.96M | 35.62M | 36.58M | 32.22M | 30M | 29.64M | 23M | 20.05M | 20.34M | 15.17M | 15.69M | 15.77M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 1.87M | 1.87M | 1.87M | 1.87M | n/a | 50.62M | 50.57M | 101.19M | 101.19M | 50.57M | 50.62M | n/a |
Operating Expenses | 67.84M | 62.67M | 57.02M | 55.37M | 55.05M | 52.49M | 49.9M | 47.86M | 48.53M | 44.18M | 41.66M | 41.77M | 35.02M | 31.11M | 31.27M | 26.21M | 29.32M | 29.32M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.29M | 1.92M | 2.34M | 2.36M | 1.11M | 561K | 248K | 370K | 509K | 643K | 774K |
Selling & Marketing Expenses | n/a | n/a | -309K | -616K | -616K | -616K | -307K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 67.84M | 62.67M | 57.48M | 56.3M | 55.98M | 53.43M | 50.37M | 47.86M | 48.53M | 44.18M | 41.66M | 41.77M | 35.02M | 31.11M | 31.27M | 26.21M | 29.32M | 29.32M |
Income Tax Expense | n/a | n/a | 419.72K | 2.29M | 2.8M | 3.15M | 858.5K | -2.31M | -3.44M | -4.28M | -2.43M | -1.15M | -492K | 14K | 176K | 367K | 545K | 548K |
Shares Outstanding (Basic) | 138.28M | 138.24M | 136.63M | 137.59M | 137.59M | 136.61M | 127.67M | 127.42M | 126.73M | 126.38M | 105.19M | 101.01M | 100.95M | 100.86M | 51.91M | 61.69M | 51.91M | 51.31M |
Shares Outstanding (Diluted) | 138.28M | 138.24M | 136.63M | 137.59M | 137.59M | 136.61M | 127.67M | 127.42M | 126.73M | 126.38M | 105.19M | 101.01M | 100.95M | 100.86M | 51.91M | 61.69M | 51.91M | 51.31M |
EPS (Basic) | -0.45 | -0.4 | -0.36 | -0.36 | -0.36 | -0.36 | -0.32 | -0.31 | -0.34 | -0.33 | -0.36 | -0.51 | -0.5 | -1.49 | -1.56 | -1.45 | -1.5 | -0.54 |
EPS (Diluted) | -0.45 | -0.4 | -0.36 | -0.36 | -0.36 | -0.36 | -0.32 | -0.31 | -0.34 | -0.33 | -0.36 | -0.51 | -0.5 | -1.49 | -1.56 | -1.45 | -1.5 | -0.54 |
EBITDA | -66.66M | -60.17M | -54.88M | -53.59M | -53.27M | -51.55M | -48.48M | -44.66M | -44.69M | -39.89M | -37.39M | -38.88M | -32.88M | -29.47M | -29.66M | -23.92M | -26.93M | -26.9M |
EBIT | -66.66M | -61.82M | -56.63M | -55.45M | -55.13M | -53.43M | -50.37M | -34.97M | -23.05M | -9.71M | -7.18M | -20.18M | -26.04M | -26.04M | -26.19M | -21.14M | -24.25M | -29.32M |
Depreciation & Amortization | 1.19M | 1.65M | 1.75M | 1.86M | 1.86M | 1.87M | 1.89M | 1.91M | 1.93M | 1.95M | 1.9M | 1.82M | 1.74M | 1.65M | 1.62M | 2.3M | 2.33M | 2.35M |